Business

Decision to Cease Development of US Respiratory Product

Decision to Cease Development of US Respiratory Product

Genetic Signatures Ltd.May 26, 20244
Decision to Cease Development of US Respiratory Product

About this update from Genetic Signatures Ltd.

Genetic Signatures Ltd has released a press release. View Attachment

View stock analysis, news, and events for Genetic Signatures Ltd.

More from Genetic Signatures Ltd.

FY26 Market Update

August 24, 2026

GSS responds to the BCAL Diagnostics Announcement

July 2, 2026

All Genetic Signatures Ltd. news →